ESSA Pharma Alpha and Beta Analysis
| EPIXDelisted Stock | USD 0.20 0.00 0.00% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as ESSA Pharma. It also helps investors analyze the systematic and unsystematic risks associated with investing in ESSA Pharma over a specified time horizon. Remember, high ESSA Pharma's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to ESSA Pharma's market risk premium analysis include:
Beta 5.69 | Alpha (2.42) | Risk 4.07 | Sharpe Ratio (0.22) | Expected Return (0.90) |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
ESSA |
ESSA Pharma Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. ESSA Pharma market risk premium is the additional return an investor will receive from holding ESSA Pharma long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in ESSA Pharma. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate ESSA Pharma's performance over market.| α | -2.42 | β | 5.69 |
ESSA Pharma Fundamentals Vs Peers
Comparing ESSA Pharma's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze ESSA Pharma's direct or indirect competition across all of the common fundamentals between ESSA Pharma and the related equities. This way, we can detect undervalued stocks with similar characteristics as ESSA Pharma or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of ESSA Pharma's fundamental indicators could also be used in its relative valuation, which is a method of valuing ESSA Pharma by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare ESSA Pharma to competition |
| Fundamentals | ESSA Pharma | Peer Average |
| Return On Equity | -0.21 | -0.31 |
| Return On Asset | -0.15 | -0.14 |
| Current Valuation | (99.33 M) | 16.62 B |
| Shares Outstanding | 47.31 M | 571.82 M |
| Shares Owned By Insiders | 5.61 % | 10.09 % |
| Shares Owned By Institutions | 73.70 % | 39.21 % |
| Number Of Shares Shorted | 1.35 M | 4.71 M |
ESSA Pharma Opportunities
ESSA Pharma Return and Market Media
The Stock received some media coverage during the period. Price Growth (%) |
| Timeline |
| ESSA Pharma dividend paid on 22nd of August 2025 | 08/22/2025 |
1 | ESSA Pharma Amends Agreement with XenoTherapeutics, Adjusts Shareholder Terms - MSN | 09/26/2025 |
2 | Can ESSA Pharma Inc. stock continue upward trend - Market Movement Recap AI Driven Stock Price Forecasts - newser.com | 10/01/2025 |
3 | ESSA Pharma Inc Stock Analysis and Forecast - Momentum Trading Signals Market Volatility Strategies - earlytimes.in | 10/07/2025 |
About ESSA Pharma Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including ESSA or other delisted stocks. Alpha measures the amount that position in ESSA Pharma has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
ESSA Pharma Upcoming Company Events
As portrayed in its financial statements, the presentation of ESSA Pharma's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, ESSA Pharma's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of ESSA Pharma's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of ESSA Pharma. Please utilize our Beneish M Score to check the likelihood of ESSA Pharma's management manipulating its earnings.
| 6th of February 2024 Upcoming Quarterly Report | View | |
| 14th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 10th of December 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 30th of September 2023 Last Financial Announcement | View |
Build Portfolio with ESSA Pharma
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Consideration for investing in ESSA Stock
If you are still planning to invest in ESSA Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ESSA Pharma's history and understand the potential risks before investing.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |